Clinical Trial Update: A Single and Multiple Ascending Dose Study of JNJ-64457744 [Phase 1]

View source ↗

Summary

Phase 1 single- and multiple-ascending-dose study of JNJ-64457744 was terminated, including participants who were healthy and with chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• JNJ-64457744 (JNJ-64457744)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Healthy, Hepatitis B, Chronic | Phase 1 | Status: TERMINATED